| __timestamp | Protagonist Therapeutics, Inc. | Sanofi |
|---|---|---|
| Wednesday, January 1, 2014 | 7459000 | 4667000000 |
| Thursday, January 1, 2015 | 11831000 | 5082000000 |
| Friday, January 1, 2016 | 25705000 | 5232000000 |
| Sunday, January 1, 2017 | 46181000 | 5567000000 |
| Monday, January 1, 2018 | 59497000 | 6350000000 |
| Tuesday, January 1, 2019 | 65003000 | 6018000000 |
| Wednesday, January 1, 2020 | 74506000 | 5529000000 |
| Friday, January 1, 2021 | 126006000 | 5692000000 |
| Saturday, January 1, 2022 | 126215000 | 6706000000 |
| Sunday, January 1, 2023 | 120161000 | 6728000000 |
| Monday, January 1, 2024 | 7394000000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Sanofi and Protagonist Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Sanofi consistently allocated a significant portion of its resources to R&D, with expenditures peaking at approximately $6.7 billion in 2023. This represents a steady increase of around 44% from 2014. In contrast, Protagonist Therapeutics, a smaller player, showed a remarkable growth trajectory, with R&D spending surging by over 1,500% during the same period, reaching about $120 million in 2023. This strategic focus underscores the dynamic nature of the pharmaceutical industry, where both established giants and emerging innovators are vying for breakthroughs that could redefine healthcare.
Who Prioritizes Innovation? R&D Spending Compared for Sanofi and Insmed Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Sanofi and BioMarin Pharmaceutical Inc.
Comparing Innovation Spending: Sanofi and CymaBay Therapeutics, Inc.
R&D Spending Showdown: Sanofi vs Vericel Corporation
Research and Development Investment: Sanofi vs Bausch Health Companies Inc.
R&D Insights: How Sanofi and Geron Corporation Allocate Funds
R&D Insights: How Sanofi and Supernus Pharmaceuticals, Inc. Allocate Funds
R&D Spending Showdown: Incyte Corporation vs Protagonist Therapeutics, Inc.
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Protagonist Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Protagonist Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development Expenses Breakdown: Protagonist Therapeutics, Inc. vs Wave Life Sciences Ltd.
Protagonist Therapeutics, Inc. vs MiMedx Group, Inc.: Strategic Focus on R&D Spending